Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...
Vietnam Investment Review on MSN
Everest Medicines closes licensing deal with Travere for civorebrutinib
SHANGHAI, July 7, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...
RHHBY announces positive phase III Krascendo 1 results for divarasib in KRAS G12C NSCLC, showing PFS and OS gains versus ...
Which Is a Better Investment, Recursion Pharmaceuticals, Inc. or Syndax Pharmaceuticals, Inc. Stock?
Learn more about whether Recursion Pharmaceuticals, Inc. or Syndax Pharmaceuticals, Inc. is a better investment based on AAII ...
Detailed price information for Bridgebio Pharma Inc (BBIO-Q) from The Globe and Mail including charting and trades.
Roche announces positive result in Phase III trial of cancer drug divarasib: Basel Friday, July 3, 2026, 17:00 Hrs [IST] Roche announced positive results from the phase III Krasce ...
Early-life stressors such as childhood trauma, abuse, or neglect increase the likelihood of developing mental illness.
Bad news for Just For Men.
Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.
Rashes, itching and fatigue are among the common side effects of immunotherapy. An oncologist explains how the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results